January 21, 2020 by Chain Drug Review
Centers for Medicare & Medicaid Services, National Community Pharmacists Association, NCPA, Ronna Hauser
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — In comments to the Centers for Medicare & Medicaid Services, the National Community Pharmacists Association urged the agency to enhance coverage of pharmacist-provided care services and reevaluate strict supervision requirements as well as coverage policies for incident-to services. In response to President Trump’s Executive Order #13890 on Protecting and Improving Medicare for
January 25, 2019 by Chain Drug Review
Centers for Medicare & Medicaid Services, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”, National Association of Chain Drug Stores (NACDS, proposal to reform direct and indirect remuneration (DIR) fees
Leading Headlines, Pharmacy

ARLINGTON, Va.—Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees – reform
February 27, 2018 by Chain Drug Review
2017-2018 flu vaccine, Centers for Medicare & Medicaid Services, effectiveness of the flu vaccine, Food and Drug Administration, influenza A H3N2, Scott Gottlieb, World Health Organization
Leading Headlines, Pharmacy, Retail News

SILVER SPRING, Md. — The Food and Drug Administration has begun efforts to improve flu vaccine effectiveness, according to FDA commissioner Scott Gottlieb. In a statement released yesterday, Gottlieb cited less protection against the influenza A H3N2 virus as a chief reason for the low efficacy of the 2017-2018 flu vaccine. The Centers for Disease
February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 12, 2018 by Mark Baumgartner and Chain Drug Review
Centers for Medicare & Medicaid Services, Medicaid, Medicaid work requirements, Trump administration
2018, Issue 02-12-2018, Issues, News
WASHINGTON — The Trump administration has issued guidance that opens the door to work requirements for Medicaid recipients, a major change in the 50-year-old program offering a safety net for Americans living in or near poverty. The White House touted the move for Medicaid work requirements as “making a positive and lasting difference” in the
February 9, 2018 by CDR Blog and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, independent pharmacy owners, Medicare Part D, National Community Pharmacists Association, NCPA, S. 413 / H.R. 1038
CDR Blog

Suffice it to say, community pharmacies are getting squeezed by retroactive DIR fees. That’s what the results of a survey from the National Community Pharmacists Association said. NCPA reported Friday that, because of retroactive direct and indirect remuneration fees, 84% of independent pharmacy owners polled said they don’t know what their final reimbursement will be at
January 17, 2018 by Chain Drug Review
Centers for Medicare & Medicaid Services, DIR fees at the point of sale, Medicare Part D, Medicare Part D for 2019, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, Steve Anderson
Leading Headlines, Pharmacy, Retail News

WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association have submitted comments to the Centers for Medicare & Medicaid Services (CMS) as it mulls Medicare Part D prescription drug program changes for the 2019 contract year. NACDS said Wednesday that in its comments to CMS the association expressed support for and provided added input
January 15, 2018 by Chain Drug Review
B. Douglas Hoey, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services, CMS-4182-P Medicare Program, community pharmacies, DIR fees, Medicare Part D, National Community Pharmacists Association, NCPA, PBM business model, pharmacy benefit managers
2018, Issue 01-15-2018, Issues, Opinion

WASHINGTON — In recent testimony before the House of Representatives Energy and Commerce Subcommittee on Health, National Community Pharmacists Association (NCPA) chief executive officer B. Douglas Hoey said pharmacists can drive better health outcomes and reduce costs, but first pharmacy benefit managers’ problematic business practices must be addressed through legislative and regulatory channels. As an
January 1, 2018 by Travis Jackson and Chain Drug Review
. This political stalemate isn’t entirely new. Americans have fought over the federal, Centers for Medicare & Medicaid Services, health coverage reform, King & Spalding, Medicare Advantage, Travis Jackson, U.S. health care system, value-based care
2018, Issue 01-01-2018, Issues, Leading Headlines, Opinion

The U.S. health care system does not work well for patients or providers. We now pay twice as much as other developed countries for health care, and the Centers for Medicare & Medicaid Services (CMS) expects Americans will spend $1 out of every $5 on health care by 2025. Our country does not get much
November 22, 2017 by Bill Schiffner
Centers for Medicare & Medicaid Services, Comprehensive Addiction and Recovery Act of 2016, Medicare Part D, NACDS, National Council for Prescription Drug Programs, Steven Anderson
Leading Headlines, Pharmacy, Retail News

ARLINGTON, Va. – The National Association of Chain Drug Stores has analyzed the Centers for Medicare & Medicaid Services’ (CMS) proposed Medicare Part D changes, and found progress on topics related to advancing e-prescribing and medication therapy management (MTM); further addressing opioid issues in a pro-patient and pro-pharmacy manner; and fostering pharmacy access. CMS’ approaches
November 20, 2017 by Geoff Walden and Chain Drug Review
Brian Fitzpatrick, Centers for Medicare & Medicaid Services, Gigi Kwik Gronvall, H.R. 4236, Johns Hopkins Center for Health Security, NACDS, National Association of Chain Drug Stores, opioid abuse, opioid crisis, opioid prescriptions, Seema Verma, Steve Anderson
2017, Issue 11-20-2017, Issues, News
BALTIMORE — Pharmacy can be key to thwarting opioid abuse, National Association of Chain Drug Stores president and chief executive officer Steve Anderson told a government summit on the opioid crisis. “Advancing the health and safety of patients, families, communities and the nation remains the priority of pharmacies, and confronting the opioid abuse epidemic is
November 10, 2017 by Chain Drug Review
Brian Fitzpatrick, Centers for Medicare & Medicaid Services, Gigi Kwik Gronvall, H.R. 4236, NACDS, National Association of Chain Drug Stores, opioid abuse, opioid abuse epidemic, Seema Verma, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy, Retail News

BALTIMORE — Pharmacy can be key to thwarting opioid abuse, National Association of Chain Drug Stores president and chief executive officer Steve Anderson told a government summit on the crisis. “Advancing the health and safety of patients, families, communities and the nation remains the priority of pharmacies, and confronting the opioid abuse epidemic is essential
October 26, 2017 by Chain Drug Review
Centers for Medicare & Medicaid Services, Medicaid pharmacy reimbursement, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, Washington State Health Care Authority, Washington State Pharmacy Association, WSPA
Featured Articles, Leading Headlines, Pharmacy, Retail News

OLYMPIA, Wash. — The National Association of Chain Drug Stores, National Community Pharmacists Association and Washington State Pharmacy Association (WSPA) are challenging changes to Medicaid pharmacy reimbursement in Washington state. NACDS said Thursday that it teamed with NCPA and WSPA in filing a legal brief last week for a case involving the changes, which the
October 23, 2017 by Chain Drug Review
Buddy Carter, Centers for Medicare & Medicaid Services, Department of Health and Human Services, DIR fees, Don Wright, Medicare Part D, NASP, National Association of Specialty Pharmacy, Seema Verma, Sheila Arquette, StopDIRfees.com
2017, Issue 10-23-2017, Issues, Opinion

WASHINGTON — The National Association of Specialty Pharmacy (NASP) has commended 54 members of the House of Representatives for urging federal agencies to eliminate retroactive Medicare Part D fees charged by big pharmacy benefit managers. The lawmakers sent a letter to the Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid